Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Christina Schmitt, Katharina J. Müller, Steffen Tiedt, Nora Kramer, Isabel Manger, Samuel Knauss, Leonie Müller‐Jensen, Petra Huehnchen, Wolfgang Boehmerle, Florian Schöberl, Lucie Heinzerling, Louisa von Baumgarten
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	International Journal of Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items